Article info

Download PDFPDF
Correspondence
Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?

Authors

  1. Correspondence to Dr. David Charles Hutchings, Institute of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M139NT, UK; hutchingsdc{at}googlemail.com
View Full Text

Citation

Hutchings DC, Anderson SG, Trafford AW
Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?

Publication history

  • First published October 12, 2017.
Online issue publication 
January 18, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.